Hurotics H-Medi: Advancing Wearable Gait Rehabilitation Technology

What Is Hurotics and What Are Their Key Achievements?

Hurotics is a South Korean startup specializing in wearable robots that recently secured 25 billion won in Series A funding. According to reports from Wowtale and Globalnewstop, the funding round was led by Atinum Investment and announced on October 15, 2026.

This latest investment brings the company’s cumulative funding to more than 33.5 billion won, which is approximately $22.8 million.

How Does the Hurotics H-Medi Exosuit Work?

The H-Medi device is a medical gait rehabilitation soft exosuit designed to be worn like clothing. It is certified by the Ministry of Food and Drug Safety as a Class 2 or Class II combination medical device.

The system functions using cable-and-tendon actuation technology that mimics the way human muscles contract. Sensors integrated into the suit analyze a user's walking conditions in real time to calculate and provide the specific amount of force needed.

The Engineering Team Behind Hurotics H-Medi

Hurotics was founded in July 2022 by Lee Ki-wook, a professor in the School of Mechanical Engineering at Chung-Ang University. Before starting the company, Lee conducted research on garment-type wearable robots at the Wyss Institute at Harvard University, where he led the DARPA Warrior Web project.

The company maintains a staff of approximately 47 employees, with about 45% of them holding master's or doctoral degrees. Leading the product development and mass production is Chief Technology Officer Seung-hoon Han, a former executive at Samsung Electronics and Hyundai Motor Group. Chief Marketing Officer Dong-soo Kim, a former rehabilitation medicine specialist at Severance Hospital, works to ensure the products reflect specific clinical needs.

Clinical Applications of Hurotics Gait Rehabilitation

Since the commercialization of the H-Medi device in September 2025, it has been introduced at Severance Hospital in Sinchon, Chung-Ang University Hospital, and Korea University Hospital. In June 2026, the device was exported to the University of Illinois Chicago for use in stroke rehabilitation research and physical therapist training. Hurotics is currently building clinical evidence through research with medical institutions while pursuing business expansion in Japan and Southeast Asia.

Recent Advancements in Gait Training Robotics

CEO Lee Ki-wook, who was the first author of a 2019 Science cover paper on a walking and running assistance robot, aims to ensure that movement recovery starting in hospitals leads to improved health in everyday life. To achieve this, the company is using new funding to accelerate the global expansion of its H-Medi device and the commercialization of its new H-Care robot.

H-Care is designed for everyday walking assistance, and the company is moving toward its development and mass production. This aligns with broader trends in Asian MedTech, where companies are securing capital to support technology development and international expansion.

Hurotics is also working to build a wearable physical AI data platform. This platform will include personalized gait algorithms and services designed to predict fall risks and sarcopenia.

The company plans to cooperate with its investors to expand its hospital supply and distribution networks. These efforts also involve upgrading the company's existing data and software platforms to support its entry into overseas markets.

Hurotics Funding and Investment Milestones

The company’s Series A funding round was led by Atinum Investment. Existing financial investors, including Stonebridge Ventures, the Industrial Bank of Korea, Aju IB Investment, and WONIK Investment Partners, also participated in this follow-on investment.

New investors joined the round, including Mirae Asset Venture Investment. Several strategic investors from the healthcare, retail, distribution, and IT sectors also supported the round, specifically Daewoong, Naver, and Lotte.